Sakar Healthcare Limited
SAKAR · NSE · ₹1,007 a share (close of 05 Oct 2026)
Available company data, source links and archived checks for Sakar Healthcare Limited. Read each source and date: a past check is not a fresh review, and some earlier figures have incomplete source details.
Revenue rose 38.4%; Net profit was ₹10.28 crore.
Quarter ended 2026-06-30 · consolidated · Company filing
Recorded quarterly figures
| Quarter | Revenue / income | YoY |
Profit | YoY | Net margin | Source |
|---|
| Jun 2026 | Revenue: ₹73 cr | +38.4% | Net profit: ₹10 cr | +120.2% | 14.1% | Company filing source |
| Mar 2026 | Revenue: ₹71 cr | +41.5% | Net profit: ₹11 cr | +91.4% | 15.5% | Company filing source |
| Dec 2025 | Revenue: ₹70 cr | — | Net profit: ₹10 cr | — | 14.6% | Company filing source |
| Sep 2025 | Revenue: ₹58 cr | — | Net profit: ₹5 cr | — | 7.9% | Company filing source |
| Jun 2025 | Revenue: ₹53 cr | +28.2% | Net profit: ₹5 cr | +93.7% | 8.9% | Company filing source |
| Mar 2025 | Revenue: ₹50 cr | — | Net profit: ₹6 cr | — | 11.5% | Company filing source |
YoY means change from the same quarter a year earlier.
— means no comparable figure is available. Older entries with incomplete source
details have not been revalidated under the current checks.
Who holds it — from the filings
Sanjay S Shah 45.0%Tata Capital Healthcare Fund ii 10.4%Hbm Healthcare Investments (Cayman) Ltd 6.7%Shah Aarsh 6.3%Cobra India (Mauritius) Limited 3.9%register as filed
2026-06-30
Filing timeline — what the company told the exchange
- Sakar Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015…
28 Sep 2026 · document
- Sakar Healthcare Limited has informed the Exchange regarding Appointment of M/s. Kashyap R. Mehta & Partners as Secretarial Auditors of the Company for the term…
22 Sep 2026 · document
- Shareholders meeting. Sakar Healthcare Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 22, 2026. Furthe…
22 Sep 2026 · document
- Shareholders meeting. Sakar Healthcare Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 22, 2026…
22 Sep 2026 · document
- Analysts/Institutional Investor Meet/Con. Call Updates. Sakar Healthcare Limited has informed the Exchange about Schedule of meet on 18th Sept., 2026…
14 Sep 2026 · document
- Analysts/Institutional Investor Meet/Con. Call Updates. Sakar Healthcare Limited has informed the Exchange about Schedule of meet on 17th Sept., 2026…
14 Sep 2026 · document
- General Updates. Sakar Healthcare Limited has informed the Exchange about Sakar receives 14 oncology product new approvals in the EU (Europe), UK & Canada with …
01 Sep 2026 · document
- Sakar Healthcare Limited has informed the Exchange about Copy of Newspaper Publication…
29 Aug 2026 · document
Follow this company without reading every document yourself.
Keep its available filings, dated fact checks and disclosure alerts together.
Your saved country sets your market and its research schedule.
Start free — first week on us →
India ₹149/month · Rest of world US$4.99/month after the free trial · research, not investment
advice · cancel any time